Maria Gomis‐González

Author

Also Known As

M. Gomis-Gonzalez, M. Gomis-González, Maria Gomis-Gonzalez, Maria Gomis-González, Maria Gomis‐González, María Gomis-González

Publications

883

Citations

H-Index

Concepts

All Affiliations

Universitat Pompeu Fabra Hospital del Mar Research Institute Hospital Del Mar Municipal Institute for Medical Research Centre for Genomic Regulation

About

Maria Gomis‐González is an author at Universitat Pompeu Fabra specializing in medicine, social sciences, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	7	511
2	Social Sciences	5	5	179
3	Cognitive Science	3	3	95
4	Engineering	1	1	34
5	Behavioral Sciences	1	1	34

Maria Gomis‐González

Publications

817

Citations

H-Index

Page 1

	Year	Citations
Targeting the endocannabinoid system in the treatment of fragile X syndrome Arnau Busquets-García, Maria Gomis‐González, Thomas Guegan, Nature Medicine Cannabis UseEndocannabinoid SystemFragile X SyndromePharmacologyFragile X Spectrum	2013	233
Microglial activation underlies cerebellar deficits produced by repeated cannabis exposure Laura Cutando, Arnau Busquets-García, Emma Puighermanal, Journal of Clinical Investigation	2013	114
Dissociation of the Pharmacological Effects of THC by mTOR Blockade Emma Puighermanal, Arnau Busquets-García, Maria Gomis‐González, Neuropsychopharmacology MedicinePhysiologyMtor BlockadeExperimental PharmacologyPharmacotherapy	2013	95
Peripheral and central CB1 cannabinoid receptors control stress-induced impairment of memory consolidation Arnau Busquets-García, Maria Gomis‐González, Raj Kamal Srivastava, Proceedings of the National Academy of Sciences	2016	80
Possible Therapeutic Doses of Cannabinoid Type 1 Receptor Antagonist Reverses Key Alterations in Fragile X Syndrome Mouse Model Maria Gomis‐González, Arnau Busquets-García, Carlos Matute, Genes Possible Therapeutic DosesCannabis UseFmr1 Ko MicePsychiatryFunctional Selectivity	2016	58
Interplay between cognition and weight reduction in individuals following a Mediterranean Diet: Three-year follow-up of the PREDIMED-Plus trial Natalia Soldevila‐Domenech, Laura Forcano, Cristina Vintró‐Alcaraz, Clinical Nutrition ObesityNutritionCognitive SciencePredimed-plus TrialObesity Management	2021	43
Cannabinoid type-1 receptor blockade restores neurological phenotypes in two models for Down syndrome Alba Navarro-Romero, Anna Vázquez‐Oliver, Maria Gomis‐González, Neurobiology of Disease Down SyndromeCannabis UseFunctional SelectivityMedicineNeuropharmacology	2019	35
Hippocampal Protein Kinase C Signaling Mediates the Short-Term Memory Impairment Induced by Delta9-Tetrahydrocannabinol Arnau Busquets-García, Maria Gomis‐González, Victòria Salgado-Mendialdúa, Neuropsychopharmacology Cannabis UseMemory LossMemoryNeuroscienceNeurology	2017	34
An Alternative Maze to Assess Novel Object Recognition in Mice José F. Oliveira da Cruz, Maria Gomis‐González, Rafaël Maldonado, BIO-PROTOCOL Alternative MazeNeuropsychologyEngineeringObject CategorizationCognition	2020	34
Safety and preliminary efficacy on cognitive performance and adaptive functionality of epigallocatechin gallate (EGCG) in children with Down syndrome. A randomized phase Ib clinical trial (PERSEUS study) Cécile Cieuta‐Walti, Aida Cuenca‐Royo, Klaus Langohr, Genetics in Medicine	2022	31

Page 1